SAN DIEGO — Preliminary data from a 3-year, phase 3 clinical trial of Vyluma’s NVK002 supported its safety and efficacy as a potential treatment for myopia progression in children, according to a ...

Please provide your email address to receive an email when new articles are posted on . Combining orthokeratology lenses with atropine eye drops may lead to better myopia control but also increase ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

Over 24 months, kids using the once-nightly drops and those using placebo saw mean changes in spherical equivalent refractive error (SER) of -0.82 D (95% CI -0.96 to ...

A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo. Reduced incidence of myopia and myopic shift after 2 years of follow-up was seen in patients who ...

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

An update from Cloudbreak Pharma, Inc. ( ($HK:2592) ) is now available. Cloudbreak Pharma has announced that its wholly owned U.S. subsidiary, ADS ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Dilating eyedrops may delay ― and perhaps even prevent ― the onset of myopia in children, according to findings from a study published today in JAMA. The study was conducted by researchers in Hong ...